Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced BRAF -V600E/K-mutated melanoma: The primary analysis of an EORTC randomized phase II study (EBIN).

Details

Language :

English

ISSN :

0732183X

Volume :

42

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

177675935

Full Text :

https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA9503